A phase 2 study using ipilimumab, nivolumab, and trabectedin for previously untreated metastatic soft tissue sarcoma.

被引：3
|
作者：
Gordon, Erlinda Maria
Chua, Victoria S.
Kim, Ted T.
Chawla, Neal Shiv
Brigham, Don Arlen
Bhuiyan, Ishrat
Agulnik, Mark
Chow, Warren Allen
Chawla, St P.
机构：
[1] Sarcoma Oncol Ctr, Santa Monica, CA USA
[2] Sarcoma Oncol Res Ctr, Santa Monica, CA USA
[3] City Hope Comprehens Canc Ctr, Duarte, CA USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.11562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11562
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase 1/2 study of safety/efficacy using trabectedin, ipilimumab and nivolumab triple therapy as first line treatment of advanced soft tissue sarcoma.
    Gordon, Erlinda Maria
    Chua-Alcala, Victoria S.
    Kim, Katherine
    Andrali, Shiva Sreenath
    Del Rosario, Marie
    Tseng, William W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Seven year update on SOC-1702: A phase 2 study using trabectedin (T) in combination with ipilimumab (I), nivolumab (N) and trabectedin (T) in previously untreated patients with advanced soft tissue sarcoma
    Gordon, Erlinda Maria
    Chawla, Sant P.
    Omelchenko, Nadezhda
    Jeffrey, Samantha
    Agarwal, Anmol Dia
    Kumar, Vaishali
    Chawla, Neal Shiv
    Chua, Victoria
    Quon, Doris V.
    Moradkhani, Ania
    Federman, Noah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Five-year results of a phase 2 trial using ipilimumab (I), nivolumab (N), and trabectedin (T) for previously untreated advanced soft tissue sarcoma (NCT03138161).
    Gordon, Erlinda Maria
    Chawla, Sant P.
    Chua-Alcala, Victoria S.
    Kim, Ted T.
    Adnan, Noufil
    Sekhon, Simranjit
    Angel, Nicole
    Fernando, Mitchel
    Brigham, Don Arlen
    Quon, Doris V.
    Moradkhani, Ania
    Wong, Steve
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] SAINT: Results of a phase 1/2 study of safety/efficacy using safe amounts of ipilimumab, nivolumab, and trabectedin as first-line treatment of advanced soft tissue sarcoma.
    Gordon, Erlinda Maria
    Chua-Alcala, Victoria S.
    Kim, Katherine
    Liu, Seiya
    Angel, Nicole
    Baby, Rekha
    Brigham, Don
    Tseng, William W.
    Pollack, Seth
    Jones, Robin Lewis
    Federman, Noah
    Srikureja, Amor M.
    Jalas, John
    Chawla, Sant P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] A phase 2 study of talimogene laherparepvec, nivolumab, and trabectedin (TNT) in advanced sarcoma.
    Chawla, Neal Shiv
    Kim, Ted
    Sherman, Travis
    Dang, Jonathan
    Chua, Victoria S.
    Moradkhani, Ania
    Bhuiyan, Ishrat
    Krkyan, Nathalie
    Fernando, Mitchel
    Colletti, Emma
    Feske, William
    Zheng, Kitty
    Chow, Warren Allen
    Agulnik, Mark
    Quon, Doris
    Chawla, Sant P.
    Gordon, Erlinda Maria
    Singh, Arun S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Phase 1/2 study of safety/efficacy using trabectedin, ipilimumab, and nivolumab as first- line treatment of advanced soft tissue sarcoma (STS).
    Gordon, Erlinda Maria
    Chua-Alcala, Victoria S.
    Kim, Katherine
    Tseng, William W.
    Quon, Doris M.
    Chawla, Sant P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [7] Clinical experience with combination chemo-/immunotherapy using trabectedin and nivolumab for advanced soft tissue sarcoma.
    Chawla, Sant P.
    Sankhala, Kamalesh Kumar
    Ravicz, Joshua
    Kang, Grace
    Liu, Seiya
    Stumpf, Nathan
    Leong, Bryan
    Kim, Seth
    Arasheben, Susan
    Tseng, William W.
    Gordon, Erlinda Maria
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] The SAINT: Initial results of a phase I/II study of safety/efficacy using safe amounts of ipilimumab, nivolumab, and trabectedin as first-line treatment of advanced soft tissue sarcoma.
    Chawla, Sant P.
    Chua-Alcala, Victoria S.
    Kim, Katherine
    Assudani, Nupur
    Al-Shihabi, Ahmad
    Moradkhani, Ania
    Quon, Doris
    Wong, Steven
    Tseng, William W.
    Pollack, Seth
    Srikureja, Amor M.
    Jalas, John
    Jones, Robin Lewis
    Gordon, Erlinda Maria
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [9] Randomized phase II trial of trofosfamide vs. adriamycin in elderly patients with previously untreated metastatic soft tissue sarcoma.
    Hartmann, Joerg Thomas
    Kopp, Hans Georg
    Gruenwald, Viktor
    Piperno-Neumann, Sophie
    Kunitz, Annegret
    Hofheinz, Ralf
    Mueller, Lothar
    Geissler, Michael
    Horger, Marius
    Fix, Peter
    Chemnitz, Jens
    Eckert, Robert
    von Weyhern, Claus Hann
    Bauer, Sebastian
    Mayer, Frank
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma
    Gordon, Erlinda Maria
    Chawla, Sant P.
    Tellez, Walter Andree
    Younesi, Elan
    Thomas, Sonu
    Chua-Alcala, Victoria S.
    Chomoyan, Hripsime
    Valencia, Chrysler
    Brigham, Don Arlen
    Moradkhani, Ania
    Quon, Doris
    Srikureja, Amornchit
    Wong, Steven G.
    Tseng, William
    Federman, Noah
    [J]. CANCERS, 2023, 15 (03)
12345